ACADIA Pharmaceuticals(ACAD) - 2025 Q4 - Earnings Call Transcript

ACADIA Pharmaceuticals (NasdaqGS:ACAD) Q4 2025 Earnings call February 25, 2026 04:30 PM ET Company ParticipantsAl Kildani - Senior Vice President of Investor Relations and Corporate CommunicationsAsh Verma - DirectorCaroline Palavicino-Maggio - VPCatherine Owen Adams - CEODavid Hoang - DirectorElizabeth Thompson - EVP and Head of Research and DevelopmentJason Butler - Managing DirectorJulian Pino - AssociateMarc Goodman - Senior Managing Director in NeuroscienceMark Breidenbach - DirectorMark Schneyer - CFO ...